The CurQD® Protocol is a meaningful addition to your toolkit for nutritional support aimed at promoting gut well-being. We use naturally sourced, research-informed botanical formulations within an easy-to-implement structure.
Extensive published research across multiple regions continues to examine the use of CurQD® in gut-related wellness settings.
To explore this work and many additional studies involving CurQD®, please visit the Science Page.
How It Works
The CurQD® formulas contain herbal extracts in differing graded concentrations tailored to the individual:
Cura:
Curcumin is the active compound extracted from the turmeric rhizome. This polyphenol has been studied extensively for its antioxidative properties and its interactions with several biological pathways relevant to cellular balance and gut-related research.
Scientific literature has examined:
NF-κB signaling pathways and how curcumin interacts with them
(Study reference: National Library of Medicine)
Interleukin-1–related activity, including research exploring curcumin’s influence on cytokine-associated signaling
(Study reference: Autoimmunity Highlights)
Reactive oxygen species (ROS)–related pathways, including how curcumin has been studied in relation to ROS-generating enzymes
(Study reference: Frontiers in Pharmacology)
Lipid peroxidation processes, with several papers examining curcumin’s effects in oxidative-stress environments
(Study reference: Arteriosclerosis, Thrombosis, and Vascular Biology).
Collectively, these studies highlight the range of scientific interest in curcumin and how it behaves within various biological systems.
QD1:
Qing Dai contains compounds with antioxidative activity that have been studied for their roles in supporting a balanced inflammatory environment and encouraging a healthy microbial landscape.
Indirubin, one of its major components, has been reported to influence NF-κB signaling (Qi, Oncotarget. 2017). Qing Dai has also been studied for its engagement with the AhR pathway and its impact on cytokines-related signaling (Gu, Sci Rep. 2020).
Qing Dai contains ligands for the aryl hydrocarbon receptor (AhR) a receptor studied for its role in communication between immune cells, epithelial surfaces, and microbial populations within the intestine.
The Protocols
Following extensive development and years of research, we combined QD1 and Cura into several carefully structured ratios—each designed for different stages of a gut-support routine, from the initial phase through long-term maintenance.
With an online assessment, convenient shipping options, and optional expert support, following the CurQD® Protocol from home is designed to be simple and accessible.
CurQD® is effective for:
-
-
-
- Supporting a healthy gut
- Naturally sourced ingredients
- Safe for children 8+
-
-
Guidelines
Dosing & Personalization
• Protocols are individualized based on an online assessment provided through the assessment page.
• Adjustments over time follow observed responses and standardized ratio progressions.
Monitoring Recommendations
• A liver-enzyme blood test is recommended 4–6 weeks after beginning QD1.
• Mild, temporary elevations in transaminases (up to ~5× ULN) have been observed in a small proportion of users and may normalize with continued or adjusted dosing.
• Higher elevations are uncommon; if they occur, discontinuation of QD1 may be advised while Cura is often continued separately when appropriate.
Expected Early Reactions
• Mild headache may occur in 5–10% of individuals beginning QD1 and typically resolves with continued use, temporary dose reduction, or brief pause and restart.
Safety Notes
• Historical reports from Japan involving non-standard Qing Dai products have mentioned rare cases of pulmonary-related events. Such events have not been reported among individuals using CurQD®.
• As a precaution, QD1 is not recommended for individuals with a personal or family history of pulmonary arterial hypertension (PAH), deep-vein thrombosis (DVT), or serious cardiovascular, cerebrovascular, or liver conditions.
• Qing Dai has been rarely associated in literature with temporary episodes such as colonic narrowing or intussusception, typically resolving after discontinuation and conservative care.
Drug Interaction Considerations
• Curcumin is generally considered to have minimal interaction potential, but standard drug-interaction resources or our medical team may be consulted.
• No medication interactions have been documented to date with QD1.
Contraindications
• Not recommended during pregnancy.
In case of further questions please don’t hesitate to contact us at info@curqd.com.